Health
FDA gives expedited approval to new groundbreaking pancreatic cancer drug
Headline as filed by The Guardian Health. PageNews does not write or rewrite headlines.
PageNews Brief
One publisher, The Guardian Health, has reported this so far, at 16:48 UTC on 26 August 2026.
No other outlet PageNews follows has covered it. If one files, their report will be added to this page and the comparison below will fill out.
The coverage is filed under Health. The publisher's own headline, summary and link is below.
Compiled by PageNews from the report listed below — who filed it and when. No publisher wrote this section.
Coverage from 1 publisher
-
The Guardian Health
FDA gives expedited approval to new groundbreaking pancreatic cancer drug
FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancerThe US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most co
Read on The Guardian Health →
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.